|
STIL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.187600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.187000E-01 |
| Normal-vs-Stage2 |
1.768020E-01 |
| Normal-vs-Stage3 |
6.228400E-01 |
| Normal-vs-Stage4 |
8.790000E-01 |
| Stage1-vs-Stage2 |
4.634200E-02 |
| Stage1-vs-Stage3 |
5.122200E-01 |
| Stage1-vs-Stage4 |
9.167800E-01 |
| Stage2-vs-Stage3 |
2.521400E-01 |
| Stage2-vs-Stage4 |
1.918200E-01 |
| Stage3-vs-Stage4 |
7.414200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.626200E-01 |
| Normal-vs-AfricanAmerican |
7.576800E-01 |
| Normal-vs-Asian |
4.059400E-01 |
| Caucasian-vs-AfricanAmerican |
7.790600E-01 |
| Caucasian-vs-Asian |
1.145150E-01 |
| AfricanAmerican-vs-Asian |
3.127800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.863400E-01 |
| Normal-vs-Female |
6.982000E-01 |
| Male-vs-Female |
8.390800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.497200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.928790E-01 |
| Normal-vs-Age(61-80Yrs) |
7.925600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.588400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.798700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.088400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.442000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.504400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.636200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.152200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.952800E-01 |
| Classical-VS-Follicular |
6.15699999999553E-05 |
| Classical-VS-Other |
2.090800E-01 |
| Classical-VS-Normal |
7.508600E-01 |
| Tall-VS-Follicular |
1.152410E-02 |
| Tall-VS-Other |
1.933400E-01 |
| Tall-VS-Normal |
4.977800E-01 |
| Follicular-VS-Other |
9.516600E-01 |
| Follicular-VS-Normal |
3.841600E-02 |
| Other-VS-Normal |
3.931200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.270000E-01 |
| Normal-vs-N1 |
9.587800E-01 |
| N0-vs-N1 |
3.020400E-01 |
|
|
